Healthcare & Life Sciences
Asklepios BioPharmaceutical, Inc. (AskBio)
Spainwww.askbio.com/
activeseries-c-plus
series-c-plus
Stage
2008
Founded
2
Investors
About
AskBio is a gene therapy company developing adeno-associated virus (AAV) based treatments for rare genetic diseases, including investigational therapies for late-onset Pompe disease.
Explore Asklepios BioPharmaceutical, Inc. (AskBio)'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.